3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Prostatic Neoplasms
21
Uterine Cervical Neoplasms
16
Esophageal Neoplasms
3
Endometrial Neoplasms
3
Breast Neoplasms
3
Vaginal Neoplasms
2
Rhabdomyosarcoma
2
Parkinson Disease 4, Autosomal Dominant Lewy Body
2
Neoplasms
2
Melanoma
2
Uveal Melanoma
1
Uterine Neoplasms
1
Sarcoma
1
Retinoblastoma
1
Recurrent Head and Neck Carcinoma
1
Radiation Injuries
1
Prostatic Diseases
1
Neuroectodermal Tumors, Primitive, Peripheral
1
Metastatic Malignant Female Reproductive System Neoplasm
1
Lung Neoplasms
1
Locally Advanced Cervical Adenocarcinoma
1
Gynecologic Cancer
1
Esophageal Squamous Cell Carcinoma
1
Endometrial Clear Cell Adenocarcinoma
1
Desmoplastic Small Round Cell Tumor
1
Cervical Adenocarcinoma
1
Carcinosarcoma
1
Carcinoma, Renal Cell
1
Carcinoma, Hepatocellular
1
Carcinoma, Ductal, Breast
1
Interventions
Cisplatin
26
Paclitaxel
21
pembrolizumab
15
Radiotherapy
13
Carboplatin
13
tislelizumab
12
Fluorouracil
12
Drug Therapy
11
Irinotecan
9
toripalimab
8
Esophagectomy
8
Oxaliplatin
6
Nivolumab
6
Capecitabine
6
Neoadjuvant Therapy
5
Leucovorin
5
Docetaxel
5
lenvatinib
4
camrelizumab
4
Taxes
4
Radiation
4
Levoleucovorin
4
Immune Checkpoint Inhibitors
4
Albumin-Bound Paclitaxel
4
130-nm albumin-bound paclitaxel
4
spartalizumab
3
sintilimab
3
apatinib
3
Itraconazole
3
Injections
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Esophageal Squamous Cell Carcinoma
×
Brachytherapy
×
1 year
×
Clear all
NCT07152678
2025-09-03
BRIGHT-ESCC
National Taiwan University Hospital
Phase 2
Recruiting
60 enrolled